Share 'AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy'
This is good news, even though the timeline is not that good -- 2 years for this Phase(?):
Estimated Enrollment: 16
Study Start Date: January 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Let's hope that this will not delay the entry of the PPMO in trials.
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this